Tap into education and guidance to support you and your patients along their treatment journey
APP/patient conversation tool
Supports APP-to-patient communication about the treatment journey, including how to help patients start and stay on treatment with DARZALEX® + Rd
Treatment duration brochure
Outlines the proven benefits of long-term DARZALEX® + Rd treatment and provides APPs with ongoing support to help keep patients on treatment longer
Patient Care Navigator brochure
Provides patients with an overview of the program and how to enroll for one-on-one support
Dosing and administration guide
Provides step-by-step instructions on how to administer DARZALEX FASPRO® and DARZALEX®
Dosing and administration video
Demonstrates how to administer an injection of DARZALEX FASPRO®
Common questions and answers about treatment with DARZALEX FASPRO® and DARZALEX® for newly diagnosed, transplant-ineligible multiple myeloma
Explore FAQsIf you are a US healthcare professional, please provide your ZIP Code and contact information below if you would like us to get in touch with you.
The information you provide will be used by Janssen Biotech, Inc., our affiliates, and our service providers to contact you. Our Privacy Policy further governs the use of the information you provide.
*Required field.
Loading...
MOA=mechanism of action; Rd=lenalidomide (R) + dexamethasone (d).